Retinoic acid (RA): An inhibitor of 5α-reductase in human prostatic cancer cells
- 1 December 1987
- journal article
- research article
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 28 (6) , 731-736
- https://doi.org/10.1016/0022-4731(87)90405-5
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Rapid analysis of C19-steroid metabolism by high-performance liquid chromatography and in-line monitoring of radioactivityJournal of Chromatography A, 1998
- Effect of hormones on growth and ATP content of a human prostatic carcinoma cell line, LNCaP‐rThe Prostate, 1985
- Membrane origin for a signal eliciting a program of cell differentiationExperimental Cell Research, 1984
- Vitamin A and Retinoids in Health and DiseaseNew England Journal of Medicine, 1984
- Comparative C19‐Radiosteroid Metabolism in Primary Monolayer Cultures of Epithelial Cells and Fibroblasts from Rat Ventral Prostate, Canine Prostate, and Rat LungJournal of Andrology, 1982
- Trial of an aromatic retinoid in patients with solid tumoursBritish Journal of Cancer, 1982
- Terminal differentiation of human promyelocytic leukemic cells in primary culture in response to retinoic acidBlood, 1981
- Reversal of methylcholanthrene-induced changes in mouse prostates in vitro by retinoic acid and its analoguesBritish Journal of Cancer, 1976
- The steroid 5α-reductase activity of rat liver and prostateBiochimie, 1971
- TISSUE CHANGES FOLLOWING DEPRIVATION OF FAT-SOLUBLE A VITAMINThe Journal of Experimental Medicine, 1925